Publications by authors named "Lisa Mucha"

Claim this Profile
T
Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients Diagnosed With Locally Advanced/Metastatic Urothelial Carcinoma Prior to Receiving Enfortumab Vedotin: A Real-World Evidence Study.
Alicia K Morgans, Lisa Mucha, Christina Quicquaro, Vanessa Shih, Bin Xie

Int J Urol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States.
Ronald C Chen, Rupali Fuldeore, Alexandra Greatsinger, Zsolt Hepp, Qing Liu, Lisa Mucha

Urol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab.
Alicia K Morgans, Guru P Sonpavde, Vanessa Shih, Phoebe Wright, Zsolt Hepp, Lisa Mucha

Clin Genitourin Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding.
Andrea B Apolo, Christine Michaels-Igbokwe, Nicholas I Simon, David J Benjamin, Mallory Farrar, Lisa Mucha

Patient· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world prevalence of adverse events with first-line systemic therapies among patients with metastatic castration-sensitive prostate cancer.
Umang Swami, Bin Xie, Christopher Young, Krishnan Ramaswamy, Nader El-Chaar, Lisa Mucha

Prostate· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use, dose intensity, and adherence to enfortumab vedotin in locally advanced or metastatic urothelial cancer.
Ronac Mamtani, Konstantinos Tsingas, Ravi B Parikh, Dina Elsouda, Lisa Mucha

Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network.
Christina B Ching, Kimberley Dickinson, John Karafilidis, Nicole Marchesani, Lisa Mucha

Eur J Pediatr· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysis.
Lisa Mucha, Bernd Hoppe, Abigail Silber, Zheng Wang, Gavin Miyasato

J Manag Care Spec Pharm· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant.
Kokuvi Atsou, Larry Ereshefsky, Mélanie Brignone, Natalya Danchenko, Françoise Diamand, Lisa Mucha

Expert Rev Pharmacoecon Outcomes Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosis.
Emma van Eijndhoven, Michelle Brauer, Rebecca Kee, Joanna MacEwan, Lisa Mucha

J Med Econ· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting the Goal Attainment Approach for Major Depressive Disorder.
Maggie McCue, Sagar V Parikh, Lisa Mucha, Sara Sarkey, Charlie Cao

Neurol Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient attitudes toward and goals for MDD treatment: a survey study.
Emily C McNaughton, Christopher Curran, Jamie Granskie, Mark Opler, Sara Sarkey, Lisa Mucha

Patient Prefer Adherence· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of relapse/recurrence in patients with major depressive disorder.
Genevieve Gauthier, Lisa Mucha, Sherry Shi, Annie Guerin

J Drug Assess· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost sharing and branded antidepressant initiation among patients treated with generics.
Jason D Buxbaum, Michael E Chernew, Machaon Bonafede, Anna Vlahiotis, Deborah Walter, Lisa Mucha

Am J Manag Care· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
Charles Vega, Russell V Becker, Lisa Mucha, Betty H Lorenz, Michael T Eaddy

Curr Med Res Opin· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staging dementia from symptom profiles on a care partner website.
Kenneth Rockwood, Matthew Richard, Chris Leibman, Lisa Mucha, Arnold Mitnitski

J Med Internet Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an informant-reported web-based data collection to assess dementia symptoms.
Kenneth Rockwood, An Zeng, Chris Leibman, Lisa Mucha, Arnold Mitnitski

J Med Internet Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Road to the nursing home: costs and disease progression among medicare beneficiaries with ADRD.
Judith Bentkover, Shubing Cai, Rajesh Makineni, Lisa Mucha, Michael Treglia

Am J Alzheimers Dis Other Demen· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the methods used to estimate the cost of Alzheimer's disease in the United States.
Josephine Mauskopf, Lisa Mucha

Am J Alzheimers Dis Other Demen· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dependence as a unifying construct in defining Alzheimer's disease severity.
Trent McLaughlin, Howard Feldman, Howard Fillit, Mary Sano, Frederick Schmitt, Lisa Mucha

Alzheimers Dement· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative assessment of the concept of dependence in Alzheimer's disease.
Lori Frank, Kellee Howard, Roy Jones, Loretto Lacey, Chris Leibman, Lisa Mucha

Am J Alzheimers Dis Other Demen· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Alzheimer's disease and association with negative health outcomes.
Daniel C Malone, Trent P McLaughlin, Peter M Wahl, Christopher Leibman, H Michael Arrighi, Lisa M Mucha

Am J Manag Care· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
Lisa Mucha, Sara Shaohung, Brian Cuffel, Thomas McRae, Tami L Mark

J Manag Care Pharm· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients.
Tami L Mark, Kristen J Axelsen, Lisa Mucha, Yelena Sadkova

Am J Manag Care· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking.
Lisa Mucha, Judith Stephenson, Nicole Morandi, Riad Dirani

Gend Med· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis